- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01628497
Exhaled NO Testing in Filariasis
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Region 4
-
Georgetown, Region 4, Guyana
- Georgetown Public Hospital Corporation
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Study subjects:
- recruited from patients with a chief complaint of wheezing, asthma or cough.
- assessed by a physician prior to consideration for enrollment into the study
- screened by the study investigator after evaluation by the physician
Control subjects:
Controls will be matched with cases by gender, age and region of residence. They will have non-emergent complaints without respiratory symptoms.
Beskrivning
Inclusion Criteria:
- Age 6 years or older of either gender
- Patients presenting with pulmonary symptoms a. Confirmed or suspected asthma patients: i. Patients presenting with symptoms consistent with an acute exacerbation of asthma, including:
1. Wheezing 2. Shortness of breath 3. Chest tightness 4. Cough ii. Disposition to the asthma room after triage and physician evaluation (disposition to other areas of the A&E allowed if due to no available space in the asthma room) iii. Patients are potentially eligible with or without a past history of health care provider diagnosed asthma iv. Patients are potentially eligible regardless of the number of previous episodes of wheezing (i.e. patients with a first episode of bronchospasm are potentially eligible) v. If suspected or documented to have pneumonia or a pulmonary infiltrate, patients are potentially eligible if:
- They have a dry cough (no production of purulent sputum)
- They have bronchospasm as manifested by wheezing or need for salbutamol (albuterol) breathing treatments vi. Patients with wheezing are not eligible if they:
1. Have purulent sputum production 2. Have known or suspected:
a. Tuberculosis b. Immunodeficiency c. Congestive heart failure d. Foreign body aspiration b. Patients presenting with a chief complaint of cough: i. Potentially eligible patients will have a cough of greater than one week (seven days) duration ii. Asthma room disposition is not required for these subjects iii. If suspected or documented to have pneumonia or a pulmonary infiltrate, patients are potentially eligible if:
1. They have a dry cough (no production of purulent sputum) iv. Patients with cough are not eligible if:
- Have purulent sputum production
Have known or suspected:
- Tuberculosis
- Immunodeficiency
- Congestive heart failure
- Foreign body aspiration
- Patients will be medically stable at the time of the consent process (see exclusion criteria below)
- A minimum of 2 years of continuous residence in Guyana at the time of enrollment, exclusive of short trips out of the country (at least 21 of previous 24 months physically in Guyana)
- English speaking
Exclusion Criteria:
- Patients less than 6 years of age
- Patients who do not consent to the study
- Children (<18 years) without a parent/guardian present
- Prisoners
Patients who appear to be medically or psychologically unstable or felt to be otherwise inappropriate for study enrollment, in the opinion of the investigator or any treating health care provider. This determination will be made on an individual basis, but some of the general criteria to be used in making this determination will be:
i. The patient appears to be in significant pain ii. The patient appears acutely ill - severe respiratory distress, diaphoretic, altered mental status, active bleeding, actively vomiting, etc.
iii. Those with respiratory difficulty to the point they cannot speak in complete sentences iv. Chief complaint of sexual assault v. The patient appears acutely intoxicated vi. The patient displays agitated, nervous, restless, or other behavior suggestive of an uncontrolled psychiatric emergency
- Patients with pulmonary findings felt to be secondary to congestive heart failure, foreign body, bacterial pneumonia, tuberculosis or other clearly defined cause
- Non-English speaking patients
- Patients without at least 2 years of residence (exclusive of short trips abroad, total of 21 of 24 previous months physically in Guyana) in Guyana at the time of enrollment
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
---|
Positive filariasis test
Those testing positive for filariasis
|
Filariasis negative
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Fil-01
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Filariasis
-
University Hospitals Cleveland Medical CenterWashington University School of Medicine; Case Western Reserve University; Papua New Guinea Institute for Medical Research och andra samarbetspartnersRekryteringEliminering av lymfatisk filariasis genom massläkemedelsadministration | Övervakning och utvärdering av massläkemedelsadministration för lymfatisk filariasis | Accepterbarhet av massläkemedelsadministration för lymfatisk filariasisPapua Nya Guinea
-
Washington University School of MedicineCase Western Reserve University; Regional Hospital of Agboville, Southern...Aktiv, inte rekryterande
-
University Hospitals Cleveland Medical CenterWashington University School of MedicineAvslutad
-
National Institute of Allergy and Infectious Diseases...Avslutad
-
The Task Force for Global HealthUnited States Agency for International Development (USAID)AvslutadLymfödem | Lymfatisk filariasis | FilariasisMali
-
National Institute of Allergy and Infectious Diseases...Avslutad
-
Washington University School of MedicineNational Institute of Allergy and Infectious Diseases (NIAID)Avslutad
-
Washington University School of MedicineIndian Council of Medical Research; Case Western Reserve UniversityAvslutadLymfatisk filariasisHaiti, Indien, Indonesien, Papua Nya Guinea
-
The Task Force for Global HealthUnited States Agency for International Development (USAID)AvslutadLymfödem | Lymfatisk filariasis | FilariasisIndien
-
The Task Force for Global HealthUnited States Agency for International Development (USAID)AvslutadLymfödem | Lymfatisk filariasis | FilariasisSri Lanka